These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1301991)

  • 1. Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus.
    Fonseca E; Alvarez R; González MR; Pascual D
    Lupus; 1992 Aug; 1(4):265-8. PubMed ID: 1301991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
    Tiao J; Feng R; Carr K; Okawa J; Werth VP
    J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study Group.
    Sachse C; Lüthke K; Hartung K; Fricke M; Liedvogel B; Kalden JR; Peter HH; Lakomek HJ; Henkel E; Deicher H
    Rheumatol Int; 1995; 15(1):23-9. PubMed ID: 7652462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticardiolipin antibodies in cutaneous lupus erythematosus. Incidence and importance as a marker of vascular symptoms].
    Tebbe B; Orfanos CE
    Hautarzt; 1992 Mar; 43(3):130-3. PubMed ID: 1577600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticardiolipin antibodies in systemic lupus erythematosus: prevalence and clinical associations].
    Abumohor P; Cerda C; Neira O; Palma S; Alvarado MA; Basualdo J; Bravo M; Guzmán L
    Rev Med Chil; 1991 May; 119(5):517-23. PubMed ID: 1844289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneous lupus erythematosus and cardiolipin antibodies. Incidence and clinical significance].
    Kind P; Schuppe HC; Jung KP; Degitz K; Lakomek HJ; Goerz G
    Hautarzt; 1992 Mar; 43(3):126-9. PubMed ID: 1577599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
    Chlebus E; Wolska H; Blaszczyk M; Jablonska S
    J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
    López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticardiolipin antibodies in patients with systemic lupus erythematosus].
    Petrović R; Petrović M; Novicić-Sasić D; Damjanov N
    Srp Arh Celok Lek; 1994; 122 Suppl 1():98-100. PubMed ID: 18173204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
    Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
    Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus.
    Martínez-Cordero E; Rivera García BE; Aguilar León DE
    J Investig Allergol Clin Immunol; 1997; 7(6):596-601. PubMed ID: 9491201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on criteria of the European Academy of Dermatology and Venerology for the classification of cutaneous lupus erythematosus. I. Selection of clinical groups and study factors.
    Beutner EH; Blaszczyk M; Jablonska S; Chorzelski TP; Kumar V; Wolska H
    Int J Dermatol; 1991 Jun; 30(6):411-7. PubMed ID: 1894405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing subacute cutaneous from other types of lupus erythematosus.
    McCauliffe DP
    Lancet; 1998 May; 351(9115):1527-8. PubMed ID: 10326532
    [No Abstract]   [Full Text] [Related]  

  • 16. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus.
    McClain MT; Arbuckle MR; Heinlen LD; Dennis GJ; Roebuck J; Rubertone MV; Harley JB; James JA
    Arthritis Rheum; 2004 Apr; 50(4):1226-32. PubMed ID: 15077305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?
    Miret C; Cervera R; Reverter JC; García-Carrasco M; Ramos M; Mollà M; Font J; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(5):541-4. PubMed ID: 9307863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of antibody to C5b-9 in the subclassification of lupus erythematosus.
    Magro CM; Crowson AN; Harrist TJ
    Br J Dermatol; 1996 May; 134(5):855-62. PubMed ID: 8736325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus.
    Campos LM; Kiss MH; D'Amico EA; Silva CA
    Lupus; 2003; 12(11):820-6. PubMed ID: 14667097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.